PGIMER Chandigarh starts clinical trial of 'Sepsivac' as drug for COVID-19 treatment

Apr 29, 2020

Chandigarh (Punjab) [India], April 29 : The clinical trial to position immunomodulator Sepsivac as a drug has begun at PGIMER Chandigarh, said Dr. Ram...